Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Beneficient

NASDAQ: BENF · Finance · 9 alerts · CIK 1775734

Share price
$0.6250Close, Nov 16
Sector
Finance
Industry
Finance ServicesSIC 6199

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Beneficient filings on SEC EDGAR ↗

4:25 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Beneficient Nasdaq/NYSE Compliance Notice

Beneficient received a deficiency notice from Nasdaq on November 5, 2026, because its market value of listed securities (MVLS) fell below the $35 million minimum requirement for 30 consecutive business days. The company has until May 4, 2027, to regain compliance by maintaining an MVLS of at least $35 million for at least ten consecutive business days. The notice has no immediate effect on the listing of the company's Class A common stock (BENF) or warrants (BENFW).

Counterparty
Nasdaq
Term
180 days
4:37 PM ET 8-K
Capital Raise

Beneficient Capital Raise

Beneficient shareholders approved the issuance of Class A Common Stock to YA II PN, Ltd. (Yorkville) under an Amended and Restated Standby Equity Purchase Agreement (A&R SEPA). The approval satisfies Nasdaq Listing Rule 5635(d), allowing the company to issue shares representing more than 20% of its outstanding common stock upon the conversion of $4.0 million in promissory notes.

Counterparty
YA II PN, Ltd.
7:45 AM ET 8-K
Product Launch

Beneficient Product Launch

Beneficient announced the upcoming launch of AltLens, a technology-enabled alternative asset portfolio analytics and risk platform designed for family offices and small institutional investors. The platform, scheduled to go live in Q4 2026, provides institutional-level risk modeling, stress-testing, and allocation analysis based on historical private market data. This launch aims to capture growing demand for sophisticated oversight tools as global alternative assets under management are projected to reach $29 trillion by 2029.

6:04 AM ET 8-K
Capital Raise

Beneficient Capital Raise

Beneficient entered into subscription agreements with three of its executives and directors for the private placement of 33,019 shares of Class A common stock. The shares were sold at a price of $1.06 per share to CEO James G. Silk, Chief Fiduciary Officer Derek L. Fletcher, and Director Peter T. Cangany, Jr.

Counterparty
Peter T. Cangany, Jr., Derek L. Fletcher, and James G. Silk

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.